doi:10.3969/j.issn.1673-8640.2025.06.018

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 14

[1]	沈立松, 路瑾. 现代蛋白电泳筛查和诊断的临床应用[M]. 上海: 上海科学技术出版社, 2019.
[2]	DE NOVELLIS D, FONTANA R, CAROBENE A, et al. Serum free light-chain ratio at diagnosis is associated with early renal damage in multiple myeloma:a case series real-world study[J]. Biomedicines, 2022, 10(7):1657.
[3]	毛雪涵, 邓书会, 隋伟薇, 等. MGUS、原发性轻链型淀粉样变、MM及MM继发淀粉样变性患者的临床分析[J]. 中国实验血液学杂志, 2021, 29(3):812-818.
[4]	MILANI P, PALLADINI G, MERLINI G. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions[J]. Scand J Clin Lab Invest Suppl, 2016, 245:S113-S118.
[5]	ERDEM B K, DAVRAN F, YILMAZ V T, et al. The association of serum-free light-chain levels with markers of renal function[J]. Ren Fail, 2015, 37(6):1057-1060. DOI PMID
[6]	CHEN C, CHEN P, FANG X. The FLC dimer with lambda type may false-migrate to the position of "albumin" band by urine protein electrophoresis on Sebia agarose gel-based detection system[J]. J Clin Lab Anal, 2019, 33(2):e22658.
[7]	SÖLLING K. Polymeric forms of free light chains in serum from normal individuals and from patients with renal diseases[J]. Scand J Clin Lab Invest, 1976, 36(5):447-452. PMID
[8]	ABRAHAM R S, CHARLESWORTH M C, OWEN B A, et al. Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma[J]. Clin Chem, 2002, 48(10):1805-1811. PMID
[9]	KAPLAN B, LIVNEH A, SELA B A. Immunoglobulin free light chain dimers in human diseases[J]. ScientificWorldJournal, 2011, 11:726-735.
[10]	PERKINS M, THEILER R, LUNTE S, et al. Determination of the origin of charge heterogeneity in a murine monoclonal antibody[J]. Pharm Res, 2000, 17(9):1110-1117.
[11]	LYUBARSKAYA Y, HOUDE D, WOODARD J, et al. Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity[J]. Anal Biochem, 2006, 348(1):24-39. PMID
[12]	KAPLAN B, RAMIREZ-ALVARADO M, SIKKINK L, et al. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease[J]. Br J Haematol, 2009, 144(5):705-715.
[13]	王淑惠, 孙冰梅, 高静, 等. 非浓缩尿蛋白电泳诊断2型糖尿病肾病的应用价值[J]. 医疗装备, 2017, 30(10):7-8.
[14]	陈鹏. SDS-AGE尿蛋白电泳检测在糖尿病肾病中的临床价值[J]. 实验与检验医学, 2010, 28(3):253-254.

病例	尿蛋白定量检测									尿mAlb/ TP比值/%
病例	TP/（mg·L^-1）		mAlb/（mg·L^-1）	β₂-MG/（mg·L^-1）	RBP/（mg·L^-1）	α₁-MG/（mg·L^-1）	TF/（mg·L^-1）	IgG/（mg·L^-1）	α₂-MG/（mg·L^-1）	尿mAlb/ TP比值/%
病例1	553		7.0	0.52	0.17	15.9	1.46	3.77	0.1	1.27
病例2	2 035		278.0	21.38	3.51	39.7	18.62	16.28	0.2	13.67
病例3	2 667		71.7	64.96	34.94	86.6	6.68	3.00	0.6	2.69
病例		尿蛋白电泳
		原始样本					经β-巯基乙醇处理后
		大分子蛋白/ %	中分子蛋白/ %	小分子蛋白/ %	λ轻链/（g·L^-1）		大分子蛋白/ %	中分子蛋白/ %	小分子蛋白/ %	λ轻链/（g·L^-1）
病例1		0.0	100.0	0.0	0.24		0.0	2.3	97.7	0.29
病例2		53.3	25.8	20.9	1.91		1.0	18.5	80.5	2.52
病例3		63.0	24.0	13.0	2.04		0.0	5.1	94.9	2.95

病例	尿蛋白定量检测									尿mAlb/ TP比值/%
病例	TP/（mg·L^-1）		mAlb/（mg·L^-1）	β₂-MG/（mg·L^-1）	RBP/（mg·L^-1）	α₁-MG/（mg·L^-1）	TF/（mg·L^-1）	IgG/（mg·L^-1）	α₂-MG/（mg·L^-1）	尿mAlb/ TP比值/%
病例1	553		7.0	0.52	0.17	15.9	1.46	3.77	0.1	1.27
病例2	2 035		278.0	21.38	3.51	39.7	18.62	16.28	0.2	13.67
病例3	2 667		71.7	64.96	34.94	86.6	6.68	3.00	0.6	2.69
病例		尿蛋白电泳
		原始样本					经β-巯基乙醇处理后
		大分子蛋白/ %	中分子蛋白/ %	小分子蛋白/ %	λ轻链/（g·L^-1）		大分子蛋白/ %	中分子蛋白/ %	小分子蛋白/ %	λ轻链/（g·L^-1）
病例1		0.0	100.0	0.0	0.24		0.0	2.3	97.7	0.29
病例2		53.3	25.8	20.9	1.91		1.0	18.5	80.5	2.52
病例3		63.0	24.0	13.0	2.04		0.0	5.1	94.9	2.95

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 14

Related Articles 15

Recommended Articles

Metrics